Concepts (111)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urology | 4 | 2024 | 74 | 1.420 |
Why?
|
| Nephrectomy | 6 | 2019 | 172 | 1.280 |
Why?
|
| Kidney Neoplasms | 4 | 2019 | 432 | 1.100 |
Why?
|
| Kidney Calculi | 2 | 2024 | 40 | 0.990 |
Why?
|
| Urolithiasis | 2 | 2022 | 8 | 0.940 |
Why?
|
| Internship and Residency | 6 | 2024 | 1158 | 0.870 |
Why?
|
| Ureter | 1 | 2024 | 95 | 0.820 |
Why?
|
| Ureteroscopy | 1 | 2021 | 17 | 0.780 |
Why?
|
| Urinary Tract | 1 | 2022 | 60 | 0.750 |
Why?
|
| Laparoscopy | 6 | 2019 | 501 | 0.750 |
Why?
|
| Myelolipoma | 1 | 2020 | 3 | 0.710 |
Why?
|
| Kidney Transplantation | 2 | 2024 | 628 | 0.700 |
Why?
|
| Adrenalectomy | 1 | 2020 | 35 | 0.700 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2020 | 63 | 0.670 |
Why?
|
| Back Pain | 1 | 2019 | 27 | 0.670 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2019 | 33 | 0.670 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2012 | 240 | 0.610 |
Why?
|
| Venous Thrombosis | 1 | 2020 | 180 | 0.610 |
Why?
|
| Urinary Tract Infections | 1 | 2021 | 293 | 0.570 |
Why?
|
| Stents | 1 | 2024 | 871 | 0.570 |
Why?
|
| Lithotripsy, Laser | 1 | 2017 | 12 | 0.560 |
Why?
|
| Microbiota | 1 | 2022 | 388 | 0.550 |
Why?
|
| Robotic Surgical Procedures | 2 | 2019 | 194 | 0.540 |
Why?
|
| Hospitalization | 1 | 2021 | 1726 | 0.430 |
Why?
|
| Ureteral Neoplasms | 1 | 2009 | 24 | 0.320 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2009 | 73 | 0.310 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2020 | 2056 | 0.250 |
Why?
|
| Incidental Findings | 3 | 2020 | 125 | 0.230 |
Why?
|
| Licensure | 1 | 2024 | 15 | 0.230 |
Why?
|
| Societies | 1 | 2024 | 26 | 0.230 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2009 | 542 | 0.230 |
Why?
|
| Humans | 20 | 2024 | 123163 | 0.210 |
Why?
|
| Urogenital System | 1 | 2022 | 34 | 0.200 |
Why?
|
| Para-Aortic Bodies | 1 | 2020 | 2 | 0.180 |
Why?
|
| Standard of Care | 1 | 2021 | 129 | 0.180 |
Why?
|
| Adenoma, Oxyphilic | 1 | 2020 | 9 | 0.180 |
Why?
|
| Perioperative Period | 1 | 2020 | 50 | 0.180 |
Why?
|
| Robotics | 2 | 2012 | 106 | 0.170 |
Why?
|
| Personnel Selection | 1 | 2021 | 63 | 0.170 |
Why?
|
| Middle Aged | 9 | 2020 | 25992 | 0.170 |
Why?
|
| Hemangioma | 1 | 2020 | 95 | 0.170 |
Why?
|
| Urologic Diseases | 1 | 2019 | 44 | 0.160 |
Why?
|
| Preoperative Care | 1 | 2021 | 350 | 0.160 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 1067 | 0.160 |
Why?
|
| Lymph Node Excision | 1 | 2019 | 157 | 0.160 |
Why?
|
| Guideline Adherence | 1 | 2021 | 375 | 0.160 |
Why?
|
| Patient Transfer | 1 | 2019 | 102 | 0.160 |
Why?
|
| Surgical Procedures, Operative | 1 | 2020 | 182 | 0.160 |
Why?
|
| Treatment Outcome | 4 | 2020 | 12129 | 0.160 |
Why?
|
| Lymphatic Metastasis | 1 | 2019 | 400 | 0.150 |
Why?
|
| Immunohistochemistry | 2 | 2020 | 1687 | 0.150 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 298 | 0.150 |
Why?
|
| Pulmonary Embolism | 1 | 2020 | 174 | 0.150 |
Why?
|
| Research Design | 1 | 2021 | 685 | 0.140 |
Why?
|
| Urogenital Surgical Procedures | 1 | 2017 | 9 | 0.140 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 2830 | 0.140 |
Why?
|
| Tomography, Emission-Computed | 1 | 2017 | 43 | 0.140 |
Why?
|
| Biopsy | 1 | 2020 | 1237 | 0.130 |
Why?
|
| Diuretics | 1 | 2017 | 158 | 0.130 |
Why?
|
| Ureteral Obstruction | 1 | 2017 | 105 | 0.130 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 1262 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2020 | 3543 | 0.120 |
Why?
|
| Quality of Life | 1 | 2024 | 1929 | 0.110 |
Why?
|
| United States | 3 | 2024 | 10631 | 0.110 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2013 | 40 | 0.100 |
Why?
|
| Living Donors | 1 | 2013 | 112 | 0.100 |
Why?
|
| Female | 8 | 2020 | 65489 | 0.100 |
Why?
|
| Warm Ischemia | 1 | 2012 | 15 | 0.100 |
Why?
|
| Blood Loss, Surgical | 1 | 2012 | 146 | 0.090 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2011 | 19 | 0.090 |
Why?
|
| Pelvic Neoplasms | 1 | 2011 | 21 | 0.090 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 424 | 0.090 |
Why?
|
| Teaching | 2 | 2024 | 183 | 0.090 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 5046 | 0.090 |
Why?
|
| Postoperative Complications | 1 | 2021 | 3013 | 0.080 |
Why?
|
| Immunoglobulin G | 1 | 2012 | 770 | 0.080 |
Why?
|
| Cystoscopy | 1 | 2009 | 44 | 0.080 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 1414 | 0.080 |
Why?
|
| Kidney Diseases | 1 | 2012 | 478 | 0.080 |
Why?
|
| Aged | 4 | 2020 | 19080 | 0.070 |
Why?
|
| Risk Factors | 1 | 2021 | 10008 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 2106 | 0.070 |
Why?
|
| Clinical Competence | 2 | 2023 | 972 | 0.060 |
Why?
|
| Computer-Assisted Instruction | 1 | 2024 | 51 | 0.060 |
Why?
|
| Foreign Medical Graduates | 1 | 2024 | 12 | 0.060 |
Why?
|
| Achievement | 1 | 2024 | 32 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 2838 | 0.060 |
Why?
|
| Retrospective Studies | 4 | 2019 | 16021 | 0.060 |
Why?
|
| Surveys and Questionnaires | 2 | 2024 | 3666 | 0.050 |
Why?
|
| Schools, Medical | 1 | 2023 | 114 | 0.050 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 6371 | 0.050 |
Why?
|
| Paraganglioma, Extra-Adrenal | 1 | 2020 | 12 | 0.050 |
Why?
|
| Radionuclide Imaging | 1 | 2020 | 151 | 0.050 |
Why?
|
| Male | 6 | 2020 | 60082 | 0.040 |
Why?
|
| Abdomen | 1 | 2020 | 129 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2024 | 507 | 0.040 |
Why?
|
| Adult | 3 | 2017 | 29057 | 0.040 |
Why?
|
| Radioactive Tracers | 1 | 2017 | 20 | 0.040 |
Why?
|
| Renal Elimination | 1 | 2017 | 9 | 0.040 |
Why?
|
| Metabolic Clearance Rate | 1 | 2017 | 142 | 0.030 |
Why?
|
| Symptom Assessment | 1 | 2017 | 98 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2017 | 126 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2017 | 330 | 0.030 |
Why?
|
| Pandemics | 1 | 2021 | 1101 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 2025 | 0.020 |
Why?
|
| S100 Proteins | 1 | 2011 | 46 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2011 | 53 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2011 | 108 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 1877 | 0.020 |
Why?
|
| Kidney | 1 | 2012 | 1337 | 0.020 |
Why?
|
| Young Adult | 1 | 2013 | 8862 | 0.010 |
Why?
|